Genetic variation in the lymphotoxin-alpha pathway and the risk of ischemic stroke in european populations

Stroke

Volumn 40, Issue 3, 2009, Pages 970-972

  Freilinger, Tobias ^a   Bevan, Steve ^b   Ripke, Stephan ^c   Gschwendtner, Andreas ^a   Lichtner, Peter ^d   Müller Myhsok, Bertram ^c   Wichmann, H Erich ^e,f   Markus, Hugh S ^b   Meitinger, Thomas ^d,g   Dichgans, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d Institute of Human Genetics   (Germany)

^e Institute of Epidemiology   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Genetics; LGALS2; LTA; PSMA6; Stroke

Indexed keywords

GALECTIN 2; LYMPHOTOXIN; PROTEASOME; PROTEASOME SUBUNIT ALPHA TYPE 6; UNCLASSIFIED DRUG; PSMA6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EMBOLISM; EUROPE; FEMALE; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STROKE; UNITED KINGDOM; BRAIN ISCHEMIA; CASE CONTROL STUDY; CLASSIFICATION; GENE FREQUENCY; GENETICS; LETTER; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGED; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FEMALE; GALECTIN 2; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; GERMANY; GREAT BRITAIN; HUMANS; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; STROKE;

EID: 62449323766     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.510800     Document Type: Article

References (15)

1. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999;138:S419-S420.
2. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2-II10.
3. Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M, Nakamura Y, Tanaka T. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature. 2004;429:72-75.
4. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet. 2002;32:650-654.
5. Ozaki K, Sato H, Iida A, Mizuno H, Nakamura T, Miyamoto Y, Takahashi A, Tsunoda T, Ikegawa S, Kamatani N, Hori M, Nakamura Y, Tanaka T. A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet. 2006;38:921-925.
6. Clarke R, Xu P, Bennett D, Lewington S, Zondervan K, Parish S, Palmer A, Clark S, Cardon L, Peto R, Lathrop M, Collins R. Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study. PLoS Genet. 2006;2:e107.
7. Koch W, Hoppmann P, Michou E, Jung V, Pfeufer A, Mueller JC, Gieger C, Wichmann HE, Meitinger T, Schomig A, Kastrati A. Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. Hum Mol Genet. 2007;16: 1821-1827.
8. Mangino M, Braund P, Singh R, Steeds R, Thompson JR, Channer K, Samani NJ. LGALS2 functional variant rs7291467 is not associated with susceptibility to myocardial infarction in Caucasians. Atherosclerosis. 2007;194:112-115.
9. Sedlacek K, Neureuther K, Mueller JC, Stark K, Fischer M, Baessler A, Reinhard W, Broeckel U, Lieb W, Erdmann J, Schunkert H, Riegger G, Illig T, Meitinger T, Hengstenberg C. Lymphotoxin-alpha and galectin-2 SNPs are not associated with myocardial infarction in two different German populations. J Mol Med. 2007;85:997-1004.
10. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ. Genotypes and haplotypes predisposing to myocardial infarction: A multilocus case-control study. Eur Heart J. 2004;25:459-467.
11. Szolnoki Z, Havasi V, Talian G, Bene J, Komlosi K, Somogyvari F, Kondacs A, Szabo M, Fodor L, Bodor A, Melegh B. Lymphotoxin-alpha gene 252G allelic variant is a risk factor for large-vessel-associated ischemic stroke. J Mol Neurosci. 2005;27:205-211.
12. Lohmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, Meitinger T, Dichgans M. ALOX5AP gene and the PDE4D gene in a Central European population of stroke patients. Stroke. 2005; 36:731-736.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, III Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35-41.
14. Wichmann HE, Gieger C, Illig T KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67 Suppl 1:S26-S30.
15. Westfall PH, Young SS. Resampling-Based Multiple Testing. John Wiley & Sons, New York. 1993.